On USDA decisions to allow CRISPR-edited crops to forego additional regulation

Screen Shot at PM

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

The first CRISPR-edited crops . . . can be cultivated and sold without oversight by the USDA, the agency said in a pair of letters posted in April. The decisions could reduce by millions the cost of development of the crops. . . .

. . . .

Such letters from USDA have become “essential” to small companies attempting to bring to market GE plants, says Antony Evans, CEO of . . . TAXA Biotechnologies. . . . “If you don’t get a letter like that, it’s very hard to…raise any money” because investors are leery of . . . the cost-prohibitive regulatory process, he says.

. . . .

In an effort to catch up with technology, the White House has ordered the USDA, the FDA and the EPA to update. . . the Coordinated Framework for the Regulation of Biotechnology. . . .

The agencies enlisted help from a committee convened by the US National Academies of Sciences, Engineering and Medicine. The committee will attempt to predict “the likely future products of biotech . . .” and what types of risks those products might pose. . . The group . . . plans to publish a report by the end of 2016.

The full, original article is behind a paywall, Nature subscribers can read it here. Non-subscribers can purchase the article: CRISPR-edited crops free to enter market, skip regulation

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend